NGS Market Overview
The Asia-Pacific and Middle East NGS market is estimated to reach $2,370.7 million in 2027, reveals the premium market intelligence study. The study also highlights that the market is set to witness a CAGR of 17.56% during the forecast period 2022-2027.
The Asia-Pacific and Middle East NGS market is anticipated to be influenced by various factors during the forecast period 2022-2027. The factors driving growth include increasing adoption of NGS in various research and diagnostic fields, growing prevalence of non-communicable diseases, and advancement in the performance of NGS platforms.
USP of the Report
• Supply chain analysis
• Impact of COVID-19
• Region-level market segmentation by offerings, platform, throughput, technology, end user, and application
• Country-level market segmentation by platform and offerings
Analyst Perspective
To emphasize the potential of the market, Swati Sood, Principal Analyst of the report, states, “With the growing applications of NGS in healthcare such as the diagnosis of diseases and technological advancements in NSG platforms are driving the growth of the market. This market is expected to register significant growth during the forecast period 2022-2027.”
Key Companies Operating in The Market
The Asia-Pacific and Middle East NGS market is highly consolidated, with around six key players accounting for a vast majority of the market share. Key players in the Asia-Pacific and Middle East NGS market analyzed and profiled in the study involve established and players that offer various kinds of NGS platforms, consumables, and services.
The key players profiled in the report include BGI Group, Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., and Oxford Nanopore Technologies plc.
Key Questions Answered in the Report/h3>
• What are the major market drivers, challenges, and opportunities in the Asia-Pacific and Middle East NGS market?
• How is the COVID-19 pandemic impacting the Asia-Pacific and Middle East NGS market landscape?
• What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
• What are the legal requirements and framework in the Asia-Pacific and Middle East NGS market?
• What is the supply chain analysis in the Asia-Pacific and Middle East NGS market?
• What are the major applications for the companies in the region of their operation?
• Who are the leading players with significant offerings in the Asia-Pacific and Middle East NGS market?
Leave a Reply